Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Websites |
     
  4. Contact |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce Increase  
 
 

Internal Medicine

Contact

sanofi-aventis Philippines, Inc.

3F, Feliza Building
108 V.A. Rufino St., Legaspi Village, 
1229 Makati City, Philippines

Tel: (632) 859-5555
Fax: (632) 813-1676

Content :

Internal Medicine

Internal medicine is the practice of preventing and treating very diverse and common diseases.

 

Urology: benign prostatic hyperplasia (BPH)

55 million people affected : 1 of every 2 men over 70

Benign prostatic hyperplasia (non-cancerous enlargement of the prostate gland) is responsible for significant disruption of everyday life, frequent walking at night, fatigue and depressive moods. The pathology may also be complicated by urinary infections, sexual dysfunction and acute urinary retention.

Respiratory tract infections

Upper respiratory tract infections (RTIs) such as sinusitis, tonsillitis and pharyngitis and lower RTIs such as bronchitis or community-acquired pneumonia are the most common infectious diseases.

The pathogens responsible for most of these infections, Streptococcus pneumoniae and Haemophilus influenzae, have developed resistance to many antibiotics.

Osteoporosis

Vertebral fractures / Hip fracture

In Europe, the United States and Japan, some 75 million people suffer from osteoporosis, a diffuse skeletal disease, characterized by decreased bone mass and changes in the microarchitecture of bone tissue, increasing bone fragility and the risk of fracture(1).

In the Philippines, a survey done based on Osteoporosis Self Assessment Tool for Asians suggested that11.23% women and 8.97% men over 50 are at high risk for osteoporosis. The survey also predicted that by 2020, this number will increase to 4 million.(2)

  • (1) Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med, 1993; 94:646-50
  • (2) Li-Yu J, NNHeS. Prevalence of osteoporosis and fractures among Fili¬pino adults. Phil J Int Med, 2007; 45:57-63

Rheumatoid arthritis

Rheumatoid arthritis (RA) is an autoimmune disease, a common form of arthritis that causes inflammation of the synovial membrane in joints and/or other internal organs.  An estimated 1% of the world population is affected by RA, and one in three patients will probably suffer severe functional disability after 20 years of the disease.

Estimated prevalence in Europe is 1.75 million patients in 2008 (Data Monitor report).

Diseases targeted by sanofi-aventis

  • Bacterial and parasitic infections
  • Rheumatoid arthritis
  • Osteoporosis
  • Pain & inflammation
  • Urology
  • Allergy
  • Inflammation
  • Benign prostatic hyperplasia
  • Hemorrhoids

Our products for internal medicine

Actonel® Logo
  • Actonel®
 
Arava® Logo
  • Arava®
 
Erceflora® Logo
  • Erceflora®
 
Ercefuryl® logo
  • Ercefuryl®
 
Flagentyl® Logo
  • Flagentyl®
 
Flagyl® Logo
  • Flagyl®
 
Flagystatin® Logo
  • Flagystatin®
 
Ladogal® Logo
  • Ladogal®
 
Orudis® Logo
  • Orudis®
 
Plaquenil® Logo
  • Plaquenil®
 
Rulid® Logo
  • Rulid®
 
Telfast® Logo
  • Telfast®
 
Tramal® logo
  • Tramal®
 
Xatral® Logo
  • Xatral OD®
 

Updated December 05, 2011